Intensity Therapeutics Inc. (INTS)
(Delayed Data from NSDQ)
$0.28 USD
+0.01 (3.70%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $0.28 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Intensity Therapeutics Inc. has a market cap of $13.24M, which represents its share price of $0.27 multiplied by its outstanding shares number of 49.06M. As a small-cap company, INTS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
INTS 0.28 +0.01(3.70%)
Will INTS be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for INTS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INTS
Is Cencora, Inc. (COR) Outperforming Other Medical Stocks This Year?
Has Cencora, Inc. (COR) Outpaced Other Medical Stocks This Year?
INTS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for INTS
Crossed Above 50 Day Moving Average appears for INTS after 3.7% move
Is INTS preparing to trend higher? Crossed Above 50 Day Moving Average shows up after rocketing 8.15%
Is INTS primed for upward momentum? Crossed Above 20 Day Moving Average shows up after rallying 6.22%
Technical picture remains unchanged for INTS after it falls 1.1% on September 30
12 Health Care Stocks Moving In Wednesday's Pre-Market Session